Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/41470
Title: | State-of-the-art document on optimal contemporary management of cardiomyopathies | Authors: | Seferovic, Petar M. Polovina, Marija Rosano, Giuseppe Bozkurt, Biykem Metra, Marco Heymans, Stephane MULLENS, Wilfried Bauersachs, Johann Sliwa, Karen de Boer, Rudolf A. Farmakis, Dimitrios Thum, Thomas Olivotto, Iacopo Rapezzi, Claudio Linhart, Ales Corrado, Domenico Tschope, Carsten Milinkovic, Ivan Bayes Genis, Antoni Filippatos, Gerasimos Keren, Andre Asanin, Milika Krljanac, Gordana Maksimovic, Ruzica Skouri, Hadi Ben Gal, Tuvia Moura, Brenda Volterrani, Maurizio Abdelhamid, Magdy Lopatin, Yuri Chioncel, Ovidiu Coats, Andrew J. S. |
Issue Date: | 2023 | Publisher: | WILEY | Source: | EUROPEAN JOURNAL OF HEART FAILURE, | Status: | Early view | Abstract: | Cardiomyopathies represent significant contributors to cardiovascular morbidity and mortality. Over the past decades, a progress has occurred in characterization of the genetic background and major pathophysiological mechanisms, which has been incorporated into a more nuanced diagnostic approach and risk stratification. Furthermore, medications targeting core disease processes and/or their downstream adverse effects have been introduced for several cardiomyopathies. Combined with standard care and prevention of sudden cardiac death, these novel and emerging targeted therapies offer a possibility of improving the outcomes in several cardiomyopathies. Therefore, the aim of this document is to summarize practical approaches to the treatment of cardiomyopathies, which includes the evidence-based novel therapeutic concepts and established principles of care, tailored to the individual patient aetiology and clinical presentation of the cardiomyopathy. The scope of the document encompasses contemporary treatment of dilated, hypertrophic, restrictive and arrhythmogenic cardiomyopathy. It was based on an expert consensus reached at the Heart Failure Association online Workshop, held on 18 March 2021. | Notes: | Seferovic, PM (corresponding author), Univ Belgrade, Fac Med, 8 Dr Subot, Belgrade 11000, Serbia. seferovic.petar@gmail.com |
Keywords: | Aetiology;Arrhythmogenic cardiomyopathy;Dilated cardiomyopathy;Hypertrophic cardiomyopathy;Management;Mortality;Restrictive cardiomyopathy;Treatment | Document URI: | http://hdl.handle.net/1942/41470 | ISSN: | 1388-9842 | e-ISSN: | 1879-0844 | DOI: | 10.1002/ejhf.2979 | ISI #: | 001070914100001 | Rights: | 2023 European Society of Cardiology | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
State‐of‐the‐art document on optimal contemporary management of cardiomyopathies.pdf Restricted Access | Early view | 3.8 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.